NCT05774717View on ClinicalTrials.gov

Tranexamic Acid in Rhinoplasty: Perioperative Bleeding, Edema and Ecchymosis

PHASE1RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 1, 2023

Primary Completion Date

February 1, 2026

Study Completion Date

February 1, 2026

Conditions
SurgeryPostoperative Blood Loss
Interventions
DRUG

Tranexamic acid

1 gram IV (intravenous) tranexamic acid administered in the operating room just prior to starting the case (10 minutes), at time that routine preoperative antibiotic is given.

Trial Locations (1)

37232

RECRUITING

Vanderbilt University Medical Center, Nashville

All Listed Sponsors
lead

Vanderbilt University Medical Center

OTHER